GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (OTCPK:CLTEF) » Definitions » Price-to-Tangible-Book

Calliditas Therapeutics AB (Calliditas Therapeutics AB) Price-to-Tangible-Book : (As of May. 07, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Calliditas Therapeutics AB Price-to-Tangible-Book?

As of today (2024-05-07), Calliditas Therapeutics AB's share price is $7.55. Calliditas Therapeutics AB's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-0.26. Hence, Calliditas Therapeutics AB's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Calliditas Therapeutics AB's Price-to-Tangible-Book or its related term are showing as below:

During the past 9 years, Calliditas Therapeutics AB's highest Price to Tangible Book Ratio was 17.57. The lowest was 2.51. And the median was 8.81.

CLTEF's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.73
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Calliditas Therapeutics AB's share price is $7.55. Calliditas Therapeutics AB's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.61. Hence, Calliditas Therapeutics AB's P/B Ratio of today is 12.42.


Calliditas Therapeutics AB Price-to-Tangible-Book Historical Data

The historical data trend for Calliditas Therapeutics AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Price-to-Tangible-Book Chart

Calliditas Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only - 6.12 9.44 14.89 -

Calliditas Therapeutics AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.37 14.89 - - -

Competitive Comparison of Calliditas Therapeutics AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Calliditas Therapeutics AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Calliditas Therapeutics AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Calliditas Therapeutics AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Calliditas Therapeutics AB's Price-to-Tangible-Book falls into.



Calliditas Therapeutics AB Price-to-Tangible-Book Calculation

Calliditas Therapeutics AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=7.55/-0.263
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Calliditas Therapeutics AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Calliditas Therapeutics AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Calliditas Therapeutics AB (Calliditas Therapeutics AB) Business Description

Traded in Other Exchanges
Address
Kungsbron 1, D5, Stockholm, SWE, SE-111 22
Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.